Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione
  1. Pubblicazioni

Tanacetum parthenium nel controllo e nel trattamento dell’emicrania

Articolo
Data di Pubblicazione:
2013
Citazione:
Tanacetum parthenium nel controllo e nel trattamento dell’emicrania / P. Magni, M. Ruscica, L. Steffani, R. Maffei Facino, G. Beretta, F. Gelmini, E. Rizzi, U. Marini. - In: L'INTEGRATORE NUTRIZIONALE. - ISSN 1127-6320. - 16:1(2013), pp. 9-14.
Abstract:
Tanacetum parthenium For control and treatment of migraine Summary Feverfew (Tanacetum parthenium L.) is a herb traditionally used for the control of inflammatory and painful diseases. The sesquiterpene lactone parthenolide is the most represented species among the components of the plant, and the most active. In the preparations containing feverfew, parthenolide should be formulated at 0.2% concentration at least. Control and treatment of migraine are the most interesting clinical uses of feverfew. According to available studies, feverfew use is well tolerated and is an effective treatment in controlling migraine as well in treating acute migraine attacks. Among the proposed mechanisms of action, there are inhibition of synthesis and production of prostaglandins, antagonism of serotonin receptors, inhibition of histamine release and modulation of neuroinflammation. The determination of parthenolide in food supplements is carried out by high performance liquid chromatography with UV detection, while measurement of plasma level requires more sensitive analysis systems (HPLC-MS/MS, GC-MS/ MS). The use of feverfew and its extracts represents a promising advancement in the field of food supplements for the control and treatment of migraine. The establishment of a rigorous standardization of extraction processes, stabilization and conservation of plant complex and the choice of an optimal formulation are key requirements for the reproducibility of the effect of these products.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
P. Magni, M. Ruscica, L. Steffani, R. Maffei Facino, G. Beretta, F. Gelmini, E. Rizzi, U. Marini
Autori di Ateneo:
BERETTA GIANGIACOMO ( autore )
MAGNI PAOLO ( autore )
RUSCICA MASSIMILIANO ( autore )
Link alla scheda completa:
https://air.unimi.it/handle/2434/225610
  • Aree Di Ricerca

Aree Di Ricerca

Settori (3)


Settore CHIM/08 - Chimica Farmaceutica

Settore MED/04 - Patologia Generale

Settore MED/05 - Patologia Clinica
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Progettato da Cineca | 26.1.3.0